| Epidemiology of gastric cancer KD Crew, AI Neugut World journal of gastroenterology: WJG 12 (3), 354, 2006 | 2477 | 2006 |
| Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer KD Crew, H Greenlee, J Capodice, G Raptis, L Brafman, D Fuentes, ... Journal of Clinical Oncology 25 (25), 3877-3883, 2007 | 521 | 2007 |
| Epidemiology of upper gastrointestinal malignancies KD Crew, AI Neugut Seminars in oncology 31 (4), 450-464, 2004 | 470 | 2004 |
| Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor–associated joint symptoms in women with early-stage breast cancer KD Crew, JL Capodice, H Greenlee, L Brafman, D Fuentes, D Awad, ... Journal of Clinical Oncology 28 (7), 1154-1160, 2010 | 350 | 2010 |
| Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel … DL Hershman, LH Weimer, A Wang, G Kranwinkel, L Brafman, D Fuentes, ... Breast cancer research and treatment 125, 767-774, 2011 | 286 | 2011 |
| Effect of acupuncture vs sham acupuncture or waitlist control on joint pain related to aromatase inhibitors among women with early-stage breast cancer: a randomized clinical trial DL Hershman, JM Unger, H Greenlee, JL Capodice, DL Lew, AK Darke, ... Jama 320 (2), 167-176, 2018 | 282 | 2018 |
| Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy DL Hershman, JM Unger, KD Crew, LM Minasian, D Awad, CM Moinpour, ... Journal of Clinical Oncology 31 (20), 2627-2633, 2013 | 237 | 2013 |
| High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy KD Crew, E Shane, S Cremers, DJ McMahon, D Irani, DL Hershman Journal of Clinical Oncology 27 (13), 2151-2156, 2009 | 191 | 2009 |
| Association between plasma 25-hydroxyvitamin D and breast cancer risk KD Crew, MD Gammon, SE Steck, DL Hershman, S Cremers, ... Cancer prevention research 2 (6), 598-604, 2009 | 176 | 2009 |
| Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer DL Hershman, DJ McMahon, KD Crew, S Cremers, D Irani, G Cucchiara, ... Journal of clinical oncology 26 (29), 4739-4745, 2008 | 155 | 2008 |
| Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors DL Hershman, H Greenlee, D Awad, K Kalinsky, M Maurer, G Kranwinkel, ... Breast cancer research and treatment 138, 795-806, 2013 | 124 | 2013 |
| Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy B Yu, N Douglas, MJ Ferin, GS Nakhuda, K Crew, RA Lobo, ... Cancer 116 (9), 2099-2105, 2010 | 120 | 2010 |
| A pilot randomized controlled trial of a commercial diet and exercise weight loss program in minority breast cancer survivors HA Greenlee, KD Crew, JM Mata, PS McKinley, AG Rundle, W Zhang, ... Obesity 21 (1), 65-76, 2013 | 119 | 2013 |
| Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer H Greenlee, KD Crew, J Capodice, D Awad, D Buono, Z Shi, A Jeffres, ... Breast cancer research and treatment 156, 453-464, 2016 | 113 | 2016 |
| Randomized multicenter placebo-controlled trial of omega-3 fatty acids for the control of aromatase inhibitor–induced musculoskeletal pain: SWOG S0927 DL Hershman, JM Unger, KD Crew, D Awad, SR Dakhil, J Gralow, ... Journal of clinical oncology 33 (17), 1910-1917, 2015 | 109 | 2015 |
| Ethnicity and persistent symptom burden in breast cancer survivors OS Fu, KD Crew, JS Jacobson, H Greenlee, G Yu, J Campbell, Y Ortiz, ... Journal of Cancer Survivorship 3, 241-250, 2009 | 108 | 2009 |
| Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients KD Crew, JL Capodice, H Greenlee, A Apollo, JS Jacobson, G Raptis, ... Journal of Cancer Survivorship 1, 283-291, 2007 | 104 | 2007 |
| Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon e in women with hormone receptor–negative breast cancer KD Crew, P Brown, H Greenlee, TB Bevers, B Arun, C Hudis, HL McArthur, ... Cancer prevention research 5 (9), 1144-1154, 2012 | 103 | 2012 |
| Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk KD Crew, MD Gammon, MB Terry, FF Zhang, LB Zablotska, M Agrawal, ... Cancer Epidemiology Biomarkers & Prevention 16 (10), 2033-2041, 2007 | 97 | 2007 |
| Harmonizing clinical sequencing and interpretation for the eMERGE III network H Zouk, E Venner, NJ Lennon, DM Muzny, D Abrams, S Adunyah, ... The American Journal of Human Genetics 105 (3), 588-605, 2019 | 93 | 2019 |
